MedCap AB (publ)

Total Valuation

MedCap AB (publ) carries a market capitalization of 7.91B, placing it among publicly traded companies globally. Its enterprise value stands at 6.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

MedCap AB (publ) currently has 15.00M shares outstanding.

Valuation Ratios

MedCap AB (publ) trades at a trailing price-to-earnings ratio of 33.64.

Enterprise Valuation

On an enterprise value basis, MedCap AB (publ) trades at an EV/EBITDA multiple of 25.22 and an EV/FCF ratio of 16.62. The EV/Sales ratio of 3.51 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.22 provides insight into valuation relative to core operating earnings.

Financial Position

MedCap AB (publ) maintains a current ratio of 2.64, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.59, indicating elevated leverage, while an interest coverage ratio of 11.89 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, MedCap AB (publ) has paid 53.00M in income taxes, reflecting an effective tax rate of 20.92.

Stock Price Statistics

MedCap AB (publ)'s stock has gained approximately 7.12106% over the past 52 weeks. The 50-day moving average sits at 511.35, while the 200-day moving average is 520.88.

Income Statement

Over the trailing twelve months, MedCap AB (publ) generated 1.90B in revenue and converted that into 198.60M in net income, yielding earnings per share of 13.38. EBITDA reached 265.10M, while operating income came in at 265.10M.

Balance Sheet

MedCap AB (publ) holds 335.10M in cash and equivalents against 335.10M in total debt, resulting in a net debt position of -274.50M.

Cash Flow

MedCap AB (publ) produced 326.00M in operating cash flow over the past twelve months. After subtracting -58.70M in capital expenditures, free cash flow totaled 267.30M - equivalent to 17.93 per share.

Margins

MedCap AB (publ) operates with a gross margin of 58.17, reflecting its pricing power and cost economics. The operating margin of 13.93 and net profit margin of 10.44 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

MedCap AB (publ)'s most recent stock split took place on September 27, 2016 with a 10:1 split ratio.

Scores

MedCap AB (publ) posts an Altman Z-Score of 8.06, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.